Immunotherapies against cancer rely on the functionality of effector cells against a variety of tumors. Effector cells, including CD4, CD8 T-Cells and Natural Killer (NK) cells, recognize tumors by ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the introduction of a new range of StarBright Dyes, ...
Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to develop a ...
News-Medical.Net on MSN
Recent advances in CAR-NK cell therapy could revolutionze cancer treatment
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback